Grey Wolf Animal Health Corp.

TSXV:WOLF Stok Raporu

Piyasa değeri: CA$25.4m

Grey Wolf Animal Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Grey Wolf Animal Health has been growing earnings at an average annual rate of 57.4%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been growing at an average rate of 7.8% per year. Grey Wolf Animal Health's return on equity is 2.7%, and it has net margins of 2.7%.

Anahtar bilgiler

57.4%

Kazanç büyüme oranı

57.4%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi23.1%
Gelir büyüme oranı7.8%
Özkaynak getirisi2.7%
Net Marj2.7%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

These 4 Measures Indicate That Grey Wolf Animal Health (CVE:WOLF) Is Using Debt Reasonably Well

Aug 23
These 4 Measures Indicate That Grey Wolf Animal Health (CVE:WOLF) Is Using Debt Reasonably Well

It's Down 25% But Grey Wolf Animal Health Corp. (CVE:WOLF) Could Be Riskier Than It Looks

Apr 19
It's Down 25% But Grey Wolf Animal Health Corp. (CVE:WOLF) Could Be Riskier Than It Looks

Grey Wolf Animal Health Corp.'s (CVE:WOLF) Shares Not Telling The Full Story

Jan 22
Grey Wolf Animal Health Corp.'s (CVE:WOLF) Shares Not Telling The Full Story

Gelir ve Gider Dağılımı

Grey Wolf Animal Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

TSXV:WOLF Gelir, gider ve kazançlar (CAD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 24261100
31 Mar 24250100
31 Dec 23251100
30 Sep 23257100
30 Jun 23245100
31 Mar 23244110
31 Dec 22233110
30 Sep 2222-3100
30 Jun 2219-390
31 Mar 2216-270
31 Dec 2113-160
31 Dec 208-140

Kaliteli Kazançlar: WOLF has high quality earnings.

Büyüyen Kar Marjı: WOLF's current net profit margins (2.7%) are lower than last year (21.9%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: WOLF's earnings have grown significantly by 57.4% per year over the past 5 years.

Büyüme Hızlandırma: WOLF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: WOLF had negative earnings growth (-86.7%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-40.8%).


Özkaynak Getirisi

Yüksek ROE: WOLF's Return on Equity (2.7%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin